Fiche publication


Date publication

novembre 2022

Journal

Scientific reports

Auteurs

Membres identifiés du Cancéropôle Est :
Pr LANG Hervé


Tous les auteurs :
Ingels A, Bensalah K, Beauval JB, Paparel P, Rouprêt M, Lang H, Nouhaud FX, Hénon F, Bruyère F, Audenet F, Lebacle C, Baumert H, Long JA, Tambwe R, Charles T, Xylinas E, Waeckel T, Michiels C, Asselineau J, Bénard A, Margue G, Boissier R, Bigot P, Bernhard JC,

Résumé

We compared the outcomes of robotic-assisted partial nephrectomy (RPN) and open partial nephrectomy (OPN) using contemporary data to respond to unmet clinical needs. Data from patients included in the registry who underwent partial nephrectomy between January 01, 2014 and June 30, 2017 within 20 centres of the French Network for Research on Kidney Cancer UroCCR were collected (NCT03293563). Statistical methods included adjusted multivariable analyses. Rates of peri- and post-operative transfusion, and of surgical revision, were lower in the RPN (n = 1434) than the OPN (n = 571) group (2.9% vs. 6.0%, p = 0.0012; 3.8% vs. 11.5%, p < 0.0001; 2.4% vs. 6.7%, p < 0.0001, respectively). In multivariable analyses, RPN was independently associated with fewer early post-operative complications than OPN (overall: odds-ratio [95% confidence interval, CI] = 0.48 [0.35-0.66]; severe: 0.29 [0.16-0.54], p < 0.0001 for both) and shorter hospital stays (34% [30%; 37%], p < 0.0001). RPN was also a significantly associated with a decresedrisk of post-operative acute renal failure, and new-onset chronic kidney disease at 3 and 12 months post-surgery. There were no between-group differences in oncological outcomes. In comparison with OPN, RPN was associated with improved peri- and post-operative morbidity, better functional outcomes, and shorter hospital stays. Our results support the use of RPN, even for large and complex tumours.

Mots clés

Humans, Robotic Surgical Procedures, adverse effects, Retrospective Studies, Treatment Outcome, Nephrectomy, adverse effects, Kidney Neoplasms, surgery

Référence

Sci Rep. 2022 11 8;12(1):18981